Atlas Trials

Evaluation of the Response to Monoclonal Antibody Therapy in Severe Asthma: Research of Predictive Biomarkers in Exhaled Air

Clinical trial NCT03988790 · UNKNOWN

Trial details

NCT number
NCT03988790
Sponsor
Hopital Foch
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Asthma
Start date
2018-12-04
Primary completion
2022-12-31
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.